Medtronic plc
NYSE:MDT · New York Stock Exchange
+$0.75 today
Vol 8.26M · Avg 11.36M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Stock Ticker Earnings Waterfall
NYSE:MDT · Revenue to Net Income
Key Ratios
Analysis
$36.4B of revenue converted into $4.8B of net income for the selected period. Gross margin is 64.7% and net margin is 13.2%, showing how much revenue survives after costs and taxes. EPS is $3.73, tying the income statement back to per-share earnings.
Income Statement
Annual data · 5 periods
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $36.4B +8.4% | $33.5B +3.6% | $32.4B +3.6% | $31.2B -1.4% | $31.7B | $1.0B | $809.6M | $921.6M |
| Cost of Revenue | $12.7B +9.4% | $11.6B +3.7% | $11.2B +4.6% | $10.7B +5.7% | $10.1B | $344.8M | $725.6M | $804.0M |
| Gross Profit | $23.6B +7.9% | $21.9B +3.6% | $21.1B +3.1% | $20.5B -4.8% | $21.5B | $10.3B | $8.9B | $7.6B |
| Gross Margin | 65.0% -0.3pp | 65.3% -0.0pp | 65.3% -0.3pp | 65.7% -2.3pp | 68.0% | 45.5% | 9.8% | 28.9% |
| Research & Development | $2.9B +5.2% | $2.7B -0.1% | $2.7B +1.4% | $2.7B -1.8% | $2.7B | $378.4M | $983.2M | $1.3B |
| Selling, General & Admin | $11.8B +8.6% | $10.8B +1.1% | $10.7B +3.1% | $10.4B +1.2% | $10.3B | $1.4B | $620.6M | $923.0M |
| Operating Expenses | $17.2B +7.7% | $15.9B -0.3% | $16.0B +6.5% | $15.0B -4.9% | $15.8B | $3.6B | $5.3B | $7.0B |
| Depreciation & Amortization | $3.0B +3.4% | $2.9B +8.1% | $2.6B -1.9% | $2.7B -0.4% | $2.7B | $1.2B | $374.2M | $1.2B |
| EBITDA | $9.8B +6.4% | $9.2B +12.4% | $8.2B -5.7% | $8.7B -0.9% | $8.8B | $12.6B | -$15.2B | $6.8B |
| EBITDA Margin | 27.0% -0.5pp | 27.5% +2.1pp | 25.3% -2.5pp | 27.9% +0.2pp | 27.7% | 10.0% | 5.6% | 46.3% |
| Operating Income | $6.5B +8.6% | $6.0B +15.8% | $5.1B -6.2% | $5.5B -4.6% | $5.8B | $10.6B | $12.3B | $14.0B |
| Operating Margin | 17.8% +0.0pp | 17.8% +1.9pp | 15.9% -1.7pp | 17.6% -0.6pp | 18.2% | 18.7% | 16.6% | 24.1% |
| Interest Income | $0 | $0 | $0 | $0 | $0 | $1.3B | -$1.5B | -$1.6B |
| Interest Expense | $715.0M -1.9% | $729.0M +1.4% | $719.0M +13.1% | $636.0M +15.0% | $553.0M | $969.2M | $1.1B | $1.0B |
| Other Income / Expenses | -$331.0M -1.2% | -$327.0M -6.5% | -$307.0M -153.7% | -$121.0M +48.5% | -$235.0M | -$1.6B | -$1.5B | $1.4B |
| Income Before Tax | $6.1B +9.0% | $5.6B +16.4% | $4.8B -9.8% | $5.4B -2.8% | $5.5B | -$15.6B | $3.3B | $4.9B |
| Pre-Tax Margin | 16.9% +0.1pp | 16.8% +1.8pp | 14.9% -2.2pp | 17.2% -0.2pp | 17.4% | 13.3% | 20.8% | 18.7% |
| Income Tax Expense | $1.3B +38.8% | $936.0M -17.4% | $1.1B -28.3% | $1.6B +246.5% | $456.0M | $666.8M | $1.3B | -$1.6B |
| Net Income | $4.8B +3.0% | $4.7B +26.8% | $3.7B -2.2% | $3.8B -25.4% | $5.0B | $5.0B | $4.9B | $4.8B |
| Net Margin | 13.2% -0.7pp | 13.9% +2.5pp | 11.4% -0.7pp | 12.0% -3.9pp | 15.9% | 7.4% | 12.4% | 17.5% |
| EPS (Basic) | $4 +3.3% | $4 +31.0% | $3 -2.1% | $3 -24.5% | $4 | $1.2B | $400.8M | $703.2M |
| EPS (Diluted) | $4 +3.3% | $4 +30.8% | $3 -2.1% | $3 -24.4% | $4 | $620.6M | $766.2M | $609.4M |
| Weighted Avg Shares | $1.3B -0.3% | $1.3B -3.2% | $1.3B -0.2% | $1.3B -0.9% | $1.3B | $892.2M | $757.8M | $925.8M |
| Weighted Avg Shares (Diluted) | $1.3B -0.1% | $1.3B -3.0% | $1.3B -0.2% | $1.3B -1.4% | $1.4B | $319.6M | $1.2B | $924.4M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
CVS Health Corporation
NYSE:CVS
$125.48B
Stryker Corporation
NYSE:SYK
$119.05B
Vertex Pharmaceuticals Incorporated
NASDAQ:VRTX
$114.73B
Bristol-Myers Squibb Company
NYSE:BMY
$110.00B
GSK plc
NYSE:GSK
$101.86B
Sanofi
NASDAQ:SNY
$101.42B
McKesson Corporation
NYSE:MCK
$87.79B
HCA Healthcare, Inc.
NYSE:HCA
$83.31B
Boston Scientific Corporation
NYSE:BSX
$67.32B
Edwards Lifesciences Corporation
NYSE:EW
$49.89B
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does MDT generate?
Medtronic plc (MDT) reported $36.36B of revenue in fiscal 2026.
Is MDT profitable?
Medtronic plc (MDT) reported $4.80B of net income, with a net margin of 13.2%.
Explore More
Continue the stock analysis
Jump to another research area for this company.